Update on the role of palliative oxygen

Davidson, PM; Johnson, MJ

Update on the role of palliative oxygen

Davidson, PM

Johnson, MJ

Permalink

Publication Type:: Journal Article
Citation:: Current Opinion in Supportive and Palliative Care, 2011, 5 (2), pp. 87 - 91
Issue Date:: 2011-06-01

Closed Access

	Filename	Description	Size
	2011001125OK.pdf		392.58 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Davidson, PM https://orcid.org/0000-0003-2050-1534	en_US
dc.contributor.author	Johnson, MJ	en_US
dc.date.issued	2011-06-01	en_US
dc.identifier.citation	Current Opinion in Supportive and Palliative Care, 2011, 5 (2), pp. 87 - 91	en_US
dc.identifier.issn	1751-4258	en_US
dc.identifier.uri	http://hdl.handle.net/10453/18644
dc.description.abstract	On the basis of the findings of this review, the routine use of palliative oxygen therapy without detailed assessment of pathogenesis and reversibility of symptoms cannot be justified. Promoting self-management strategies, such as cool airflow across the face, exercise and psychological support for patients and carers, should be considered before defaulting to oxygen therapy. If palliative oxygen therapy is considered for individuals with transient or mild hypoxaemia, a therapeutic trial should be conducted with clinical review after 3 days to assess the net clinical benefit and patient preference. © 2011 Wolters Kluwer Health \| Lippincott Williams & Wilkins.	en_US
dc.relation.ispartof	Current Opinion in Supportive and Palliative Care	en_US
dc.relation.isbasedon	10.1097/SPC.0b013e3283463cd3	en_US
dc.subject.classification	Oncology & Carcinogenesis	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Dyspnea	en_US
dc.subject.mesh	Palliative Care	en_US
dc.subject.mesh	Oxygen Inhalation Therapy	en_US
dc.subject.mesh	Severity of Illness Index	en_US
dc.subject.mesh	Cost-Benefit Analysis	en_US
dc.title	Update on the role of palliative oxygen	en_US
dc.type	Journal Article
utslib.citation.volume	2	en_US
utslib.citation.volume	5	en_US
utslib.for	1110 Nursing	en_US
utslib.for	1117 Public Health and Health Services	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Nursing
utslib.copyright.status	closed_access
pubs.issue	2	en_US
pubs.publication-status	Published	en_US
pubs.volume	5	en_US

Abstract:

On the basis of the findings of this review, the routine use of palliative oxygen therapy without detailed assessment of pathogenesis and reversibility of symptoms cannot be justified. Promoting self-management strategies, such as cool airflow across the face, exercise and psychological support for patients and carers, should be considered before defaulting to oxygen therapy. If palliative oxygen therapy is considered for individuals with transient or mild hypoxaemia, a therapeutic trial should be conducted with clinical review after 3 days to assess the net clinical benefit and patient preference. © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/18644